Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population

European Journal of Immunology

Volumn 39, Issue 5, 2009, Pages 1280-1287

  Torheim, Eirik A ^a   Ndhlovu, Lishomwa C ^b   Pettersen, Frank O ^c   Larsen, Trine Lise ^a   Jha, Aashish R ^b   Torgersen, Knut M ^a   Kvale, Dag ^c   Nixon, Douglas F ^b   Taskén, Kjetil ^a   Aandahl, Einar M ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

HIV antigens; HIV type 1; IL 10; Treg

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAG PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ARTICLE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOMAGNETIC SEPARATION; IMMUNOREGULATION; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS IMMUNITY; BLOOD; CELL PROLIFERATION; CYTOLOGY; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MONONUCLEAR CELL; NONPARAMETRIC TEST;

CELL PROLIFERATION; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOMAGNETIC SEPARATION; INTERFERON-GAMMA; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 67649991445     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200839002     Document Type: Article

References (56)

1. Miedema, F., Immunological abnormalities in the natural history of HIV infection: Mechanisms and clinical relevance. Immunodefic. Rev. 1992. 3: 173-193.
2. Sheppard, H. W. and Ascher, M. S., The natural history and pathogenesis of HIV infection. Annu. Rev. Microbiol. 1992. 46: 533-564.
3. + T cells. Nature 2002. 417: 95-98.
4. Greene, W. C., A history of AIDS: Looking back to see ahead. Eur. J. Immunol. 2007. 37: S94-S102.
5. + T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J. Infect. Dis. 1995. 172: 79-87.
6. Roos, M. T., Miedema, F., Koot, M., Tersmette, M., Schaasberg, W. P., Coutinho, R. A. and Schellekens, P. T., T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. J. Infect. Dis. 1995. 171: 531-536.
7. Aandahl, E. M., Aukrust, P., Skalhegg, B. S., Muller, F., Froland, S. S., Hansson, V. and Tasken, K., Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients. FASEB J. 1998. 12: 855-862.
8. Kvale, D., Ormaasen, V., Kran, A. M., Johansson, C. C., Aukrust, P., Aandahl, E. M., Froland, S. S. and Tasken, K., Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment. AIDS 2006. 20: 813-820.
9. + T cells, modulated by cytokines and effected by lymphotoxin. AIDS 1996. 10: 603-611.
10. + T cell responses associated with control of viremia. Science 1997. 278: 1447-1450.
11. Lieberman, J., Shankar, P., Manjunath, N. and Andersson, J., Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 2001. 98: 1667-1677.
12. Kinter, A. L., Hennessey, M., Bell, A., Kern, S., Lin, Y., Daucher, M., Planta, M. et al., CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 2004. 200: 331-343.
13. + regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 2004. 78: 2454-2459.
14. + regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004. 104: 3249-3256.
15. + T cells. J. Immunol. 2002. 168: 2247-2254.
16. Andersson, J., Boasso, A., Nilsson, J., Zhang, R., Shire, N. J., Lindback, S., Shearer, G.M. and Chougnet, C. A., The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J. Immunol. 2005. 174: 3143-3147.
17. + Treg in HIV-1-infected patients with low CD4 counts. Eur. J. Immunol. 2009. 39: 301-309.
18. + suppressor T cells: More questions than answers. Nat. Rev. Immunol. 2002. 2: 389-400.
19. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 2005. 6: 345-352.
20. Belkaid, Y. and Rouse, B. T., Natural regulatory T cells in infectious disease. Nat. Immunol. 2005. 6: 353-360.
21. Rouse, B. T., Sarangi, P. P. and Suvas, S., Regulatory T cells in virus infections. Immunol. Rev. 2006. 212: 272-286.
22. Baker, C. A., Clark, R., Ventura, F., Jones, N. G., Guzman, D., Bangsberg, D. R. and Cao, H., Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection. Clin. Exp. Immunol. 2007. 147: 533-539.
23. + adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J. Immunol. 2006. 177: 246-254.
24. + regulatory T cells by continuous antigen stimulation. J. Leukoc. Biol. 2008. 83: 1111-1117.
25. Roncarolo, M. G., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K. and Levings, M. K., Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 2006. 212: 28-50.
26. + regulatory T cells. J. Immunol. 2004. 172: 5986-5993.
27. Baker, C. A., Clark, R., Ventura, F., Jones, N. G., Guzman, D., Bangsberg, D. R. and Cao, H., Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection. Clin. Exp. Immunol. 2007. 147: 533-539.
28. Simon, V. and Ho, D. D., HIV-1 dynamics in vivo: Implications for therapy. Nat. Rev. Microbiol. 2003. 1: 181-190.
29. Clerici, M., Sarin, A., Berzofsky, J. A., Landay, A. L., Kessler, H. A., Hashemi, F., Hendrix, C. W. et al., Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD41T cells, modulated by cytokines and effected by lymphotoxin. AIDS 1996. 10: 603-611.
30. Musey, L. K., Krieger, J. N., Hughes, J. P., Schacker, T. W., Corey, L. and McElrath, M. J., Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. J. Infect. Dis. 1999. 180: 278-284.
31. Sereti, I. and Lane, H. C., Immunopathogenesis of human immunodeficiency virus: Implications for immune-based therapies. Clin. Infect. Dis. 2001. 32: 1738-1755.
32. Moore, K. W., de Waal, M. R., Coffman, R. L. and O'Garra, A., Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001. 19: 683-765.
33. Filippi, C. M. and von Herrath, M. G., IL-10 and the resolution of infections. J. Pathol. 2008. 214: 224-230.
34. Accapezzato, D., Francavilla, V., Paroli, M., Casciaro, M., Chircu, L. V., Cividini, A., Abrignani, S. et al., Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J. Clin. Invest. 2004. 113: 963-972.
35. Ameglio, F., Cordiali, F. P., Solmone, M., Bonifati, C., Prignano, G., Giglio, A., Caprilli, F. et al., Serum IL-10 levels in HIV-positive subjects: Correlation with CDC stages. J. Biol. Regul. Homeost. Agents 1994. 8: 48-52.
36. Clerici, M., Wynn, T. A., Berzofsky, J. A., Blatt, S. P., Hendrix, C. W., Sher, A., Coffman, R. L. and Shearer, G. M., Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 1994. 93: 768-775.
37. Swaminathan, S., Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus. Semin. Hematol. 2003. 40: 107-115.
38. Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A. and Mosmann, T. R., Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990. 248: 1230-1234.
39. Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B. and Oldstone, M. B., Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 2006. 12: 1301-1309.
40. Ejrnaes, M., Filippi, C. M., Martinic, M. M., Ling, E. M., Togher, L. M., Crotty, S. and von Herrath, M. G., Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 2006. 203: 2461-2472.
41. Blackburn, S. D. and Wherry, E. J., IL-10, T cell exhaustion and viral persistence. Trends Microbiol. 2007. 15: 143-146.
42. Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., de Waal-Malefyt, R. et al., In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 2002. 195: 603-616.
43. + regulatory T cells. J. Immunol. 2004. 172: 5986-5993.
44. Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., Powrie, F., An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 1999. 190: 995-1004.
45. Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B. and Oldstone, M. B., Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 2006. 12: 1301-1309.
46. Mills, K. H. and McGuirk, P., Antigen-specific regulatory T cells - their induction and role in infection. Semin. Immunol. 2004. 16: 107-117.
47. + regulatory T cells. J. Immunol. 2004. 172: 5986-5993.
48. + T cells. J. Immunol. 2007. 178: 3265-3271.
49. Green, K. A., Okazaki, T., Honjo, T., Cook, W. J. and Green, W. R., The programmed death-1 and interleukin-10 pathways play a down-modulatory role in LP-BM5 retrovirus-induced murine immunodeficiency syndrome. J. Virol. 2008. 82: 2456-2469.
50. Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J. and Ahmed, R., Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006. 439: 682-687.
51. Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W. et al., PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006. 443: 350-354.
52. Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M. R. et al., Upregulation of PD-1 expression on HIV-specific CD8(+) T cells leads to reversible immune dysfunction. Nat. Med. 2006. 12: 1198-1202.
53. Clerici, M., Wynn, T. A., Berzofsky, J. A., Blatt, S. P., Hendrix, C. W., Sher, A., Coffman, R. L. and Shearer, G. M., Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 1994. 93: 768-775.
54. + T cell immunity to gag in HIV-1-infected individuals with differential disease progression: Reciprocal interferon-gamma and interleukin-10 responses. J. Infect. Dis. 2001. 184: 1268-1278.
55. + adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J. Immunol. 2006. 177: 246-254.
56. Yaqub, S., Henjum, K., Mahic, M., Jahnsen, F. L., Aandahl, E. M., Bjornbeth, B. A. and Tasken, K., Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner. Cancer Immunol. Immunother. 2007. 57: 813-821.